Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study

Oncology. 2003;64(4):477-8. doi: 10.1159/000070312.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibiotics, Antineoplastic / administration & dosage
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Drug Administration Schedule
  • Drug Resistance, Neoplasm
  • Female
  • Gemcitabine
  • Humans
  • Irinotecan
  • Middle Aged
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Deoxycytidine
  • Irinotecan
  • Camptothecin
  • Gemcitabine